Retinal Clinical Assessment With AI-derived Quantitative Information
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: AI-derived retinal quantitative information-assisted reporting.
- Who it may be relevant to
- Registry conditions: no Obvious Abnormalities, Diabetic Retinopathy (DR), AMD, Cup-to-disc Ratio Bigger Than 0.5. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
AI-derived Retinal Quantification Versus Routine Clinical Interpretation in Ophthalmic Assessment: a Randomized Controlled Trial
Overview
This randomized controlled trial evaluates whether providing clinicians with AI-derived quantitative retinal information improves the quality and efficiency of retinal clinical assessment. Participating ophthalmologists and ophthalmology trainees will be randomly assigned to one of two groups. The intervention group will write clinical reports with access to automated quantitative measurements generated from fundus image analysis, including multiple retinal structural and vascular biomarkers. The control group will complete the same reporting tasks using only the original fundus images without AI-generated quantitative information. All reports produced by both groups will be de-identified and independently evaluated by a separate panel of senior ophthalmologists who are blinded to group allocation. The expert evaluators will assess report accuracy, completeness, clarity, and overall clinical quality using predefined scoring criteria. The study aims to determine whether access to quantitative retinal biomarkers enhances clinicians' reporting performance and reduces reporting time during retinal assessment tasks.
Interventions
- Diagnostic test AI-derived retinal quantitative information-assisted reporting
Clinicians assigned to the intervention arm will complete retinal clinical reports with access to an AI system that provides automated retinal feature quantification. The system generates multiple quantitative retinal biomarkers-including vessel characteristics, optic nerve head metrics, macular indices, and other region-specific structural measurements-derived from automated segmentation of each fundus image. During report writing, clinicians can view these AI-generated quantitative values alo
Primary outcome measures
- Expert-rated clinical report quality [Time frame: Assessed after completion of all reporting tasks (approximately 1-2 weeks per participant)]
Eligibility criteria
Inclusion criteria
Clinician Participants (Report Writers)
- Board-certified ophthalmologists or ophthalmology trainees (registrars or fellows) with clinical experience in interpreting fundus images.
- Capable of independently completing retinal clinical reports based on fundus photography.
- Willing and able to participate in the study tasks (report writing) under assigned study conditions.
- Able to provide informed consent.
Expert Evaluators (Outcome Assessors)
- Senior ophthalmologists with at least 5 years of post-certification clinical experience.
- Not involved in the report-writing stage of the study.
- Willing to evaluate de-identified reports across predefined quality dimensions.
- Able to provide informed consent.
Fundus Images (Data Inputs)
- Retinal fundus photographs of sufficient quality for clinical interpretation.
- Images representing a range of common retinal findings (normal or abnormal).
- Previously collected, de-identified images with no patient-identifiable information.
Exclusion criteria
Clinician Participants
- Lack of experience in interpreting fundus images (e.g., interns, medical students).
- Prior involvement in the development, training, or validation of the AI system being tested.
- Inability to complete reporting tasks due to time constraints or technical limitations.
- Any condition that may interfere with ability to perform study tasks (e.g., prolonged absence).
Expert Evaluators
- Participation in the intervention or control reporting arms.
- Prior exposure to or involvement in development of the AI system.
- Any conflict of interest affecting impartiality of report quality evaluation.
Fundus Images
- Poor-quality images with insufficient clarity for interpretation.
- Images containing artifacts or cropping that prevent accurate segmentation or assessment.
- Images with any remaining patient identifiers (excluded to maintain confidentiality).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07291960 · TRECK2018-056-GZ(2022)-07